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Editorial Comment
Have Balloon, Will Travel:
Expanded Indications for
Nonoperative Intravascular
Balloon Dilation?*
HAROLD DASH , MD, FACC
Everett . Washington
In 1976, Gruntzig (I) reporteda modification of the original
technique for transluminal dilation of peripheral vascular
atherosclerotic stenosis. Previously, Dotter and Judkins (2)
had used progressively larger vessel dilators. passing them
sequentially across an area of stenosis to open atheroscle-
rotic obstructions in the iliofemoral circulation. The dilators
werestiff and thecomplication rate washigh. AfterGriintzig
developed the flexible balloon dilation catheter, complica-
tions decreased markedly , allowing for much wider clinical
application of transluminal angioplasty. In 1979, he and his
coworkers (3) extended balloon dilation to the coronary
circulation, and spawned a new subspecialty in cardiology
as well as a new industry in intravascular medical products.
Refinements in equipment have enabled us to proceed in
two directions: with small, steerable balloons, we have been
able to reach more distal branches of the coronary arteries;
with larger balloons, we have been able to approach major
vessels and valves. Balloon dilation equipment has now
been approved for use in the United States for the therapy
of congenital pulmonary stenosis. In addition, there are
reports of successful balloon valvuloplasty in congenital
aortic stenosis (4), rheumatic mitral stenosis (5) and coarc-
tation of the aorta (6).
Valvuloplasty of severe aortic stenosis. In this issue
of the Journal, Cribier et al. (7 ) extend the potential indi-
cations of nonoperative balloon dilation further. reporting
the first large series of adults undergoing transluminal bal-
loon valvuloplasty for severe aortic stenosis. They delib-
erately chose patientswho were sick and elderly: their mean
age was 75 years, and 73% were in New York Heart As-
sociation functional class III or IV heart failure . These pa-
tients were clearly at high risk. Had they undergone aortic
valve replacement, their perioperative mortality rate would
*Editorials published inJournal a/ the American College ofCardiology
reflect the views of the authors and do not necessarily represent the views
of JACC or the American College of Cardiology.
From The Everett Clinic. 390 1 Hoyt, Everett, Washington.
Addressfor reprints:HaroldDash. MD, The Everett Clinic. 3901 Hoyt.
Everett. Washington 98201.
<D 1987 by the American College of Cardiology
387
have been expected to be as high as 20% (8,9). Thus, the
short-term follow-up reported by Cribier et al. is encour-
aging. Procedure-related mortality was acceptable at 3%,
and clinical improvement was considerable in a group of
patients who would otherwise have been expected to have
a 50% 2 year mortality rate (10).
Yet , enthusiasm over aortic balloon valvuloplasty in adults
must be tempered by the recognition that the procedure is
palliative and that short-term complications are relatively
frequent. The large size of the balloon accounts for the high
(7%) incidence of vascular complications reported by Cri-
bier et al. (the 15 mm balloon makes a 12F hole and the
larger balloons make a 14F hole). Although systemic em-
bolism was not reported in this series of patients, I suspect
we will see case reports in the future, because fracture of
nodular valve calcifications is one of the potential mecha-
nisms for successful dilation in degenerative aortic steno-
sis (II ).
We should also reserve judgment about the procedure
until we have much longerfollow-up . The patients ofCribier
et al. were left with moderately severe aortic stenosis (valve
area 0.93 cnr'). Given that the disease is a degenerative
process, it will not be suprising if some patients with an
initially good result exhibit deterioration over time (12).
Already, the limited data available suggest that in patients
with associated multivessel coronary artery disease, pallia-
tion with balloon valvuloplastydoes not alter the poor prog-
nosis.
Implications. I believe that the results presentedby Cri-
bier et al. justify offeringpercutaneous transluminal balloon
valvuloplasty to symptomatic adults with severe aortic ste-
nosis who are not surgical candidates for aortic valve re-
placement. These patients should be entered into a registry
similar to that established for coronary angioplasty by the
National Heart, Lung, and BloodInstitute. Follow-up would
ideally include serial Doppler echocardiography to assess
valve function and serial radionuclide angiography to assess
left ventricular function, as well as clinical evaluation. If
long-term evaluation of these high risk patients confirms
sustained clinical improvement, then it will be time to or-
ganize a randomized study comparing the balloon with sur-
gery in low risk patients with symptomatic aortic stenosis.'
The author thanks Sharon Cordisco for typing the manuscript.
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